Cariprazine and Belzutifan: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Belzutifan
Cariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Belzutifan can speed up how your body handles cariprazine (Vraylar). Belzutifan can turn up a liver enzyme called CYP3A4, and that same enzyme both creates and clears cariprazine's important active forms. Because of this, cariprazine's levels can shift, and right now experts can't say for sure whether it becomes too weak, too strong, or stays about the same.
The honest answer is that this combination hasn't been studied, which is why it isn't recommended. The good news: don't stop or change anything on your own. Just let your pharmacist or prescriber know you take both, and they can decide on the safest plan and watch how you're doing.
Interaction: Belzutifan is a CYP3A4 inducer; cariprazine is a CYP3A4 substrate whose active metabolites (desmethyl- and didesmethyl-cariprazine) are both formed and eliminated via CYP3A4.
- Direction/magnitude: Net effect on cariprazine exposure is unclear and unquantified because CYP3A4 induction alters both formation and clearance of active moieties. Not formally evaluated.
- Onset: Unspecified (enzyme induction is typically delayed, over days to weeks).
- Evidence: Theoretical.
- Management: Coadministration is not recommended. If unavoidable, monitor for altered efficacy and tolerability; discuss alternatives with prescriber.
What happens
Effects on the cariprazine exposure has not been evaluated and the net effect is unclear
Interaction Deep Dive
Combining cariprazine, which serves as a substrate for CYP3A4, with a CYP3A4 inducer is advised against. The generation and clearance of cariprazine's active metabolites depend on CYP3A4. How CYP3A4 inducers influence cariprazine exposure remains unstudied, and the overall effect is uncertain1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
What your care team may do:
- Because this combination is not recommended, they may consider whether an alternative to one of the drugs is appropriate.
- If both are needed, they may monitor you more closely for changes in how well cariprazine is working (mood or psychiatric symptoms) and for side effects.
- Any dose changes would be individualized by your team, not something to adjust yourself.
What you should do: Keep taking both exactly as prescribed unless told otherwise, and tell your pharmacist or prescriber you're on both. Report any new symptoms or side effects promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Cariprazine and Belzutifan together?
Belzutifan may change cariprazine levels in a way that hasn't been studied, so this pairing isn't recommended; keep taking both as prescribed and ask your prescriber or pharmacist whether an alternative or closer monitoring is needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cariprazine and Belzutifan interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Cariprazine and Belzutifan interaction managed?
What your care team may do: Because this combination is not recommended, they may consider whether an alternative to one of the drugs is appropriate. If both are needed, they may monitor you more closely for changes in how well cariprazine is working (mood or psychiatric symptoms) and for side effects. Any dose changes would be individualized by your team, not something to adjust yourself. What yo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Cariprazine or Belzutifan need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
Keep reading about Belzutifan
Keep reading about Cariprazine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist